Department of Primary Care and Medical Education, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Department of Community General Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Trials. 2022 Aug 26;23(1):708. doi: 10.1186/s13063-022-06645-7.
The alcohol-metabolizing enzyme aldehyde dehydrogenase 2 (ALDH2) is a carcinogenic acetaldehyde-degrading enzyme, and its low activity is a genetic constitution peculiar to East Asians. People with low alcohol dehydrogenase 1B activity (ADH1B*1/*1 genotype) have a high risk of developing head and neck cancer and alcoholism. The study aims to evaluate the effectiveness of brief interventions for excessive drinking among college students and adults in their 20s, including information on five constitutions that combine the ALDH2 and ADH1B genotypes.
Participants comprised university students and staff aged 20-30 years who had consumed ≥40 g (males) or ≥20 g (females) of pure alcohol; they were classified into intervention and control groups using a simple randomization method. Participants anonymously filled out questionnaires linked to identification numbers and recorded the drinking days and amounts on the drinking calendar. The intervention group will then be tested for genotype testing using saliva (5 types of combinations of ALDH2 and ADH1B enzyme activities); the result report will arrive approximately 1 month later. We will conduct a 30-min face-to-face or online intervention. The control group will be merely given the conventional materials, and genetic testing will be performed voluntarily after 6 months (end of study). The intervention group will undergo questionnaire surveys 1 month after the intervention and 3 and 6 months after baseline. Questionnaire surveys will be conducted 1, 3, and 6 months after baseline for the control group. The average amount of drinking before and after the intervention, attribute/baseline data between the two groups, and time-series data were compared using various analysis tools. For interventions, we engaged in dialog based on intervention materials that added genotyping content to the existing materials, result reports, baseline data, and drinking calendar records. Participants' ingenuity is respected to support their drinking behavior and goal setting.
Individual information on the genetic makeup of alcohol-metabolizing enzymes provided during the intervention is more personal and objective than general health information, especially in Japan, where the ALDH2 low activity rate is high. This information may be useful for health care and precautionary measures.
R000050379, UMIN000044148, Registered on June 1, 2021. Scientific Title: Examination of simple intervention using genetic polymorphism information for excessive drinking.
酒精代谢酶乙醛脱氢酶 2(ALDH2)是一种致癌的乙醛降解酶,其低活性是东亚人的特有遗传构成。低活性的乙醇脱氢酶 1B(ADH1B*1/*1 基因型)的人患头颈部癌症和酗酒的风险很高。本研究旨在评估针对大学生和 20 多岁成年人过度饮酒的简短干预措施的有效性,其中包括结合 ALDH2 和 ADH1B 基因型的五种体质信息。
参与者为年龄在 20-30 岁之间的大学生和工作人员,他们摄入的纯酒精量≥40 克(男性)或≥20 克(女性);他们采用简单随机化方法分为干预组和对照组。参与者匿名填写与识别号码相关联的问卷,并在饮酒日历上记录饮酒天数和饮酒量。干预组将使用唾液进行基因型检测(ALDH2 和 ADH1B 酶活性的 5 种组合);大约 1 个月后将收到结果报告。我们将进行 30 分钟的面对面或在线干预。对照组仅提供常规材料,6 个月后(研究结束时)自愿进行基因检测。干预组将在干预后 1 个月以及基线后 3 个月和 6 个月进行问卷调查。对照组将在基线后 1、3 和 6 个月进行问卷调查。使用各种分析工具比较干预前后的平均饮酒量、两组之间的属性/基线数据以及时间序列数据。对于干预,我们根据干预材料进行对话,这些材料将基因分型内容添加到现有材料、结果报告、基线数据和饮酒日历记录中。尊重参与者的创造力,以支持他们的饮酒行为和目标设定。
干预过程中提供的酒精代谢酶基因构成的个人信息比一般健康信息更个性化和客观,特别是在日本,ALDH2 低活性率较高。这些信息可能对医疗保健和预防措施有用。
R000050379,UMIN000044148,于 2021 年 6 月 1 日注册。科学名称:使用遗传多态性信息进行简单干预以治疗过度饮酒的检查。